title: Bettering the lives of patients with end-stage renal disease with HomeChoice Claria with Sharesource: an interview with Dr. Bruce Culleton.
abstract: Interview with Dr. Bruce Culleton, Vice President, renal therapeutic area lead at Baxter by Tasnim Zahri (Commissioning Editor) I was fortunate enough to meet Dr. Bruce Culleton, Vice President, renal therapeutic area lead at Baxter (Deerfield, IL, USA), during the European Renal Association - European Dialysis and Transplant Association conference in London to discuss Baxter's newest dialysis system; the HomeChoice Claria automated peritoneal dialysis system with the Sharesource web-based connectivity platform. Recently awarded a CE mark, HomeChoice Claria with Sharesource is hoped to better the lives of patients with end-stage renal disease, enable effective connectivity between patients and clinicians and pave the way toward improved individualized care.
authors: a Baxter International Inc., 1 Baxter Parkway, Deerfield, IL 60015, USA.
authors: Bruce
authors: B
authors: Culleton
mesh_terms: D035843:Biomedical Research; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010530:Peritoneal Dialysis / Q000295:instrumentation*; D057285:Precision Medicine; D011788:Quality of Life